케이엠제약 / 2020.03.30 사업보고서 25. 11. 13. 오후 12:50
케이엠제약/사업보고서/2020.03.30
1. 요약재무정보
(단위:원)
사업연도
제5기
제4기
제3기
구분
2019년 12월말
2018년 12월말
2017년 12월말
[유동자산]
7,429,865,826
13,669,087,784
7,710,983,216
ㆍ당좌자산
4,216,237,461
10,409,253,614
5,406,448,538
ㆍ재고자산
3,205,172,652
3,259,834,170
2,304,534,678
[비유동자산]
35,712,938,625
19,066,627,393
16,937,532,802
ㆍ투자자산
5,178,476,124
5,208,313,321
5,236,345,411
ㆍ유형자산
24,749,831,803
9,033,473,394
10,762,423,161
ㆍ무형자산
179,853,386
4,527,476
3,263,700
ㆍ투자부동산
4,852,053,690
4,231,385,091
338,021,210
ㆍ기타비유동자산
752,723,622
588,928,111
597,479,320
자산총계
43,142,804,451
32,735,715,177
24,648,516,018
[유동부채]
3,342,260,169
3,589,674,369
6,867,756,594
[비유동부채]
15,606,176,217
5,312,217,120
3,299,140,000
부채총계
18,948,436,386
8,901,891,489
10,166,896,594
[자본금]
2,138,705,000
1,988,705,000
1,538,705,000
[자본잉여금]
26,901,593,133
25,733,905,527
4,153,512,800
[자본조정]
(166,603)
(166,603)
0
[기타포괄손익누계액]
(769,360,800)
(714,448,800)
(478,639,200)
[이익잉여금]
(4,076,402,665)
(3,174,171,436)
9,268,040,824
자본총계
24,194,368,065
23,833,823,688
14,481,619,424
매출액
20,338,372,951
17,302,126,018
16,915,184,232
영업이익
(1,526,030,613)
1,571,673,992
2,131,064,308
당기순이익
(902,231,229)
(12,330,050,360)
1,752,439,144
주당순이익(단위:원)
(43)
(735)
119
https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20200330002097
1/1